Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166673096> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2166673096 endingPage "P95" @default.
- W2166673096 startingPage "P95" @default.
- W2166673096 abstract "7-11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK HIV-protease inhibitors may increase tenofovir plasma AUC by 22-37%. Whether this affects tenofovir-diphosphate (TFV-DP) intracellular levels, especially in the presence of didanosine, which is also eliminated through active tubular secretion, is unclear. A 52-year-old HIV-1 positive Caucasian male started zidovudine (AZT), lamivudine, nelfinavir in 1999 at a CD4-cell count of 210/µL. In July 2007 treatment was switched because of viral blips to atazanavir, ritonavir, tenofovir, emtricitabine and didanosine (250 mg). Within one year his CD4-cell count declined from 1140 to 140/µL despite complete virological suppression [1]. Renal clearance (Cockgroft-Gault) decreased from 86 to 74 mL/min and renal phosphate threshold to 0.24 mmol/L (n=0.8-1.35), indicative of proximal tubular dysfunction. There was 8 kg weight loss, his serum glucose and lactate were elevated. In addition, following the ART-switch a thrombocytosis (1355x109/L) was noticed. After exclusion of other causes, essential thrombocythemia was diagnosed and hydroxyurea started. Thrombocytes were elevated before initiation of ART (427x109/L) and before therapy switch (659x109/L), suggesting AZT-related bone marrow suppression may have prevented a further increase in platelet count in the preceding years. Suspecting NRTI-related mitochondrial and tubular dysfunction, we measured intracellular ddA-TP (didanosine) and TFV-DP (tenofovir) in PBMCs [2]. TFV-DP was 10xULN (1350 fmol/106 cells) and ddA-TP 21xULN (105 fmol/106 cells). Hydroxyurea may have increased ddA-TP levels, but was used for only 2 weeks. ART was changed to AZT, lamivudine, atazanavir, ritonavir, raltegravir. Two weeks later TFV-DP was still 250 fmol/106 cells, demonstrating an intracellular t½ of approximately 140 hrs and ddA-TP 57.4 fmol/106cells, t½ 385 hrs, but didanosine and tenofovir plasma levels were undetectable. After switch his CD4-cell count increased again from 140 to 340/µL and his platelet count decreased to 725x109/L following re-initiation of AZT. Elevated TFV-DP and ddA-TP led to tubular dysfunction and mitochondrial toxicity. Inhibition of purine-nucleoside-phosphorylase by TFV-DP and DNA-polymerase-γ by ddA-TP may have caused the steep CD4-cell decline. We believe interactions between tenofovir, didanosine and atazanavir/ritonavir were responsible for this toxicity." @default.
- W2166673096 created "2016-06-24" @default.
- W2166673096 creator A5003294215 @default.
- W2166673096 creator A5012870282 @default.
- W2166673096 creator A5019123350 @default.
- W2166673096 creator A5051917075 @default.
- W2166673096 creator A5065904622 @default.
- W2166673096 creator A5066570875 @default.
- W2166673096 date "2010-01-01" @default.
- W2166673096 modified "2023-09-27" @default.
- W2166673096 title "Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline" @default.
- W2166673096 cites W2111980395 @default.
- W2166673096 cites W2134388482 @default.
- W2166673096 doi "https://doi.org/10.1186/1758-2652-13-s4-p95" @default.
- W2166673096 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3113103" @default.
- W2166673096 hasPublicationYear "2010" @default.
- W2166673096 type Work @default.
- W2166673096 sameAs 2166673096 @default.
- W2166673096 citedByCount "0" @default.
- W2166673096 crossrefType "journal-article" @default.
- W2166673096 hasAuthorship W2166673096A5003294215 @default.
- W2166673096 hasAuthorship W2166673096A5012870282 @default.
- W2166673096 hasAuthorship W2166673096A5019123350 @default.
- W2166673096 hasAuthorship W2166673096A5051917075 @default.
- W2166673096 hasAuthorship W2166673096A5065904622 @default.
- W2166673096 hasAuthorship W2166673096A5066570875 @default.
- W2166673096 hasBestOaLocation W21666730961 @default.
- W2166673096 hasConcept C126322002 @default.
- W2166673096 hasConcept C142462285 @default.
- W2166673096 hasConcept C203014093 @default.
- W2166673096 hasConcept C2522874641 @default.
- W2166673096 hasConcept C2777210460 @default.
- W2166673096 hasConcept C2777447569 @default.
- W2166673096 hasConcept C2777869810 @default.
- W2166673096 hasConcept C2779298103 @default.
- W2166673096 hasConcept C2779778239 @default.
- W2166673096 hasConcept C2779889181 @default.
- W2166673096 hasConcept C2780216070 @default.
- W2166673096 hasConcept C2780593183 @default.
- W2166673096 hasConcept C2780727368 @default.
- W2166673096 hasConcept C2780829020 @default.
- W2166673096 hasConcept C2781057849 @default.
- W2166673096 hasConcept C2781160516 @default.
- W2166673096 hasConcept C2993143319 @default.
- W2166673096 hasConcept C71924100 @default.
- W2166673096 hasConcept C89560881 @default.
- W2166673096 hasConcept C90924648 @default.
- W2166673096 hasConcept C98274493 @default.
- W2166673096 hasConceptScore W2166673096C126322002 @default.
- W2166673096 hasConceptScore W2166673096C142462285 @default.
- W2166673096 hasConceptScore W2166673096C203014093 @default.
- W2166673096 hasConceptScore W2166673096C2522874641 @default.
- W2166673096 hasConceptScore W2166673096C2777210460 @default.
- W2166673096 hasConceptScore W2166673096C2777447569 @default.
- W2166673096 hasConceptScore W2166673096C2777869810 @default.
- W2166673096 hasConceptScore W2166673096C2779298103 @default.
- W2166673096 hasConceptScore W2166673096C2779778239 @default.
- W2166673096 hasConceptScore W2166673096C2779889181 @default.
- W2166673096 hasConceptScore W2166673096C2780216070 @default.
- W2166673096 hasConceptScore W2166673096C2780593183 @default.
- W2166673096 hasConceptScore W2166673096C2780727368 @default.
- W2166673096 hasConceptScore W2166673096C2780829020 @default.
- W2166673096 hasConceptScore W2166673096C2781057849 @default.
- W2166673096 hasConceptScore W2166673096C2781160516 @default.
- W2166673096 hasConceptScore W2166673096C2993143319 @default.
- W2166673096 hasConceptScore W2166673096C71924100 @default.
- W2166673096 hasConceptScore W2166673096C89560881 @default.
- W2166673096 hasConceptScore W2166673096C90924648 @default.
- W2166673096 hasConceptScore W2166673096C98274493 @default.
- W2166673096 hasIssue "Suppl 4" @default.
- W2166673096 hasLocation W21666730961 @default.
- W2166673096 hasLocation W21666730962 @default.
- W2166673096 hasOpenAccess W2166673096 @default.
- W2166673096 hasPrimaryLocation W21666730961 @default.
- W2166673096 hasRelatedWork W2066184048 @default.
- W2166673096 hasRelatedWork W2071732113 @default.
- W2166673096 hasRelatedWork W2096675880 @default.
- W2166673096 hasRelatedWork W2110650928 @default.
- W2166673096 hasRelatedWork W2113027692 @default.
- W2166673096 hasRelatedWork W2113389936 @default.
- W2166673096 hasRelatedWork W2167865974 @default.
- W2166673096 hasRelatedWork W2443912227 @default.
- W2166673096 hasRelatedWork W2914058108 @default.
- W2166673096 hasRelatedWork W344783904 @default.
- W2166673096 hasVolume "13" @default.
- W2166673096 isParatext "false" @default.
- W2166673096 isRetracted "false" @default.
- W2166673096 magId "2166673096" @default.
- W2166673096 workType "article" @default.